Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress.
about
Alzheimer's Disease: Mechanism and Approach to Cell TherapyAlzheimer's disease and insulin resistance: translating basic science into clinical applicationsAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemMeta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks.Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer's disease.Lipid and Alzheimer's disease genes associated with healthy aging and longevity in healthy oldest-old.Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.Oxidative stress activates the transcription factors FoxO 1a and FoxO 3a in the hippocampus of rats exposed to low doses of ozoneA molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's Disease, Glioblastoma and Lung cancerPotential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trialsConcerted perturbation observed in a hub network in Alzheimer's diseaseFOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease.Identification of biomarkers of human skin ageing in both genders. Wnt signalling - a label of skin ageing?FoxO transcription factors support oxidative stress resistance in human chondrocytesComputational modelling of the regulation of Insulin signalling by oxidative stress.Obesity and the ageing brain: could leptin play a role in neurodegeneration?Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation.Cross-talk between insulin and Wnt signaling in preadipocytes: role of Wnt co-receptor low density lipoprotein receptor-related protein-5 (LRP5).Neurohormetic phytochemicals: An evolutionary-bioenergetic perspectiveFOXOs attenuate bone formation by suppressing Wnt signaling.Dysregulated FOXO transcription factors in articular cartilage in aging and osteoarthritis.Sirtuins and Their Roles in Brain Aging and Neurodegenerative DisordersBasal insulin: beyond glycemia.Peroxisome proliferator-activated receptors and Alzheimer's disease: hitting the blood-brain barrier.Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.Selenium and selenoprotein function in brain disorders.The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy.Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin.Blockade of the Interaction of Calcineurin with FOXO in Astrocytes Protects Against Amyloid-β-Induced Neuronal Death.Distinct Hippocampal Expression Profiles of Long Non-coding RNAs in an Alzheimer's Disease Model.Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.Prenatal high sucrose intake affected learning and memory of aged rat offspring with abnormal oxidative stress and NMDARs/Wnt signaling in the hippocampus.IGF-1-Mediated Survival from Induced Death of Human Primary Cultured Retinal Pigment Epithelial Cells Is Mediated by an Akt-Dependent Signaling Pathway.Oxidant/Antioxidant Imbalance in Alzheimer's Disease: Therapeutic and Diagnostic Prospects.The Phosphatidylinositol 3-Kinase/mTor Pathway as a Therapeutic Target for Brain Aging and Neurodegeneration.Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects
P2860
Q26778149-9814F209-46C9-4D3A-8F0A-AFFF32268E48Q26996487-804E22F0-94AC-4E8E-8EAA-3596D6890A04Q28389419-921AF910-0CAC-4AAB-B01A-44C1491ED085Q31047629-33E80AC6-E973-4D0A-A03E-7AE27EC116A2Q31126123-399B8984-6B1C-4E49-A264-9F5010A826C9Q33591262-22D90A91-C57B-4310-AA48-5C0FBC674C52Q33738316-E806EE66-E2BF-46DC-BD5D-E8FC7A2E8509Q33748578-B1E0AF22-446F-4039-9065-A3CF2CD56F95Q33860823-F8C58B64-CE05-4215-9EED-86E7E78FE695Q34014237-0519ACF8-F8B2-434F-B472-D89FDA885213Q34344867-12919927-A1B1-43FB-8F8D-33BB387F6610Q34415342-08EDCDD3-9DEB-40D1-AA09-22788E760029Q34505325-52268F3C-E694-406C-AE92-23522076D911Q34626746-DC9A289A-AEBC-4BA0-8195-886F8D244F2CQ34738870-BDC129F8-46DF-4921-B795-98AF90EB5DA1Q35367422-FE062BE6-A2AB-4C92-A2B1-F05A05119DFCQ35565682-2F67675E-65D8-4504-BCA5-2DEF42121FD8Q35874430-6BDCF720-70BC-4DA8-8A9E-B945B53B3114Q36101328-4C510130-3D06-410E-B463-490171CEDB25Q37052939-6E2C2E69-F8AE-4F5E-8347-63734FE98371Q37600074-C09645EA-7ED4-43EF-BD80-374602EF1C69Q37710177-7ADFEA47-6A89-40E9-827A-5DD33F8F67D2Q37890775-C8222687-0FCA-4F01-AE71-E5F5BA8C8AC2Q38089668-F99631EA-45D6-4237-AF14-25265EB09A09Q38118901-CDDBB002-A655-4646-B732-4261A760D67EQ38199451-82C2743B-6A98-43B6-9E19-4998766B0790Q38352298-340E1635-092C-4B48-837B-F0A5C229DD73Q38612548-8006B639-BD83-48B5-AFD0-06A8FE1FA1F6Q38881070-01EA999D-954A-4FCA-8CD9-57C800F706BBQ42339277-06F9712E-8C87-4BAB-B60F-3322F9FBE9C5Q46293996-FDC77872-97A0-48A6-9AFD-DB350D7489E8Q50437287-4B060020-80EA-40A5-BE73-733488E43406Q50872033-61B4A004-1D66-4396-8B64-580190F5D405Q52595131-2AEBE8EA-D35B-440F-8F71-7B2E8D8C5899Q55658995-F5EB631C-8B9C-4034-AF3E-8101CA972B6DQ57805478-58293876-6BB3-4E93-B3E8-461AFCC0B895
P2860
Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress.
@en
Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress.
@nl
type
label
Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress.
@en
Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress.
@nl
prefLabel
Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress.
@en
Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress.
@nl
P2093
P2860
P356
P1433
P1476
Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress.
@en
P2093
K N Manolopoulos
P2860
P2888
P304
P356
10.1038/MP.2010.17
P407
P577
2010-11-01T00:00:00Z
P5875
P6179
1050805307